Current position:Home >Product >
L-Ornithinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]phenyl]-
L-Ornithinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]phenyl]-(159857-81-5)
- Name: L-Ornithinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]phenyl]-
- Synonyms:maleimidocaproyl-val-Cit-PAB-OCOpNP;N-[6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-N5-carbamoyl-N[4-({[(4-nitrophenoxy)carbonyl]oxy}methyl)phenyl]-L-ornithinamide;N-[6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-N-carbamoyl-N-[4-({[(4-nitrophenoxy)carbonyl]oxy}methyl)phenyl]-L-ornithinamide;4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl (4-nitrophenyl)carbonate;N-[6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-N5-carbamoyl-N-[4-({[(4-nitrophenoxy)carbonyl]oxy}methyl)phenyl]-L-ornithinamide;maleimido-caproyl-valine-citrulline-para-aminobenzyl-4-nitrophenylcarbonate;MC-VAL-CIT-PAB-PNB;Mc-Val-Cit-PABC-PNP;
- Molecular Formula:C35H43N7O11
- Molecular Weight:737.767
- CAS Registry Number:159857-81-5
- EINECS:
- Melting Point:
- Water Solubility:
China (Mainland)] 
Assessed
Assessed
Assessed
Assessed
Assessed
Assessed
Premium
Premium
Premium
Premium
Premium
Premium
Premium
United States] 
Premium
Other Product
- 187739-60-2/CARBOXYAMIDOTRIAZOLE OROTATE
- 1262849-79-5/1,3-Pyrrolidinedicarboxylic acid, 4-[(2-chloro-6,7-dimethoxy-4-quinazolinyl)amino]-, 1-(1,1-dimethylethyl) 3-ethyl ester, (3R,4S)-rel-
- 646989-21-1/GW-300
- 1295298-72-4/CCR1 antagonist 4
- 1382992-11-1/Benzamide, N-[2-(5-chloro-1H-indol-3-yl)ethyl]-4-[(3-chlorophenyl)methyl]-
- 475205-49-3/A-317491 DISODIUM SALT
- 1396771-17-7/MST1 kinase inhibitor
- 867324-12-7/LBW242
- 902779-59-3/DICHLORO(2Z)-2-[(4-OXO-4H-1-BENZOPYRAN-3-YL)METHYLENE]HYDRAZINECARBOTHIOAMIDE COPPER COMPLEX
- 78780-98-0/1α,25,26-TrihydroxyvitaMin D3
- 473719-41-4/AMG 487
- 936850-11-2/tert-butyl 3-hydroxy-3-(1-hydroxy-2-methylpropan-2-yl)azetidine-1-carboxylate
- 1038410-88-6/JTV 519
- 1352873-82-5/IGF-1R inhibitor
- 1370261-98-5/PRT062607 acetate
- 364762-86-7/TD-198946
- 1228237-47-5/Methanol, 1-[3-[5-[2-[[(3R)-1-[(1-methyl-1H-pyrazol-3-yl)sulfonyl]-3-piperidinyl]amino]-4-pyrimidinyl]imidazo[2,1-b]oxazol-6-yl]phenoxy]-, 1-(dihydrogen phosphate)
- 1186231-83-3/TAK-441
- 1194508-25-2/Edivoxetine
- 159857-81-5/L-Ornithinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]phenyl]-
- 956590-23-1/UNBS-5162
- 855527-92-3/NBI-74330
- 1311423-89-8/Benzamide, N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[2-(dimethylamino)ethoxy]-6-ethoxy-
- 1319207-44-7/CC0651
- 406231-90-1/SZ4TA2
- 871266-63-6/PCI-27483
- 891499-69-7/CCR5 antagonist (hydrochloride)
- 308359-57-1/Zalypsis
- 882755-95-5/Phosphonic acid, [5-[2-amino-5-(2,2-dimethyl-1-oxopropyl)-4-thiazolyl]-2-furanyl]-
- 865854-05-3/4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione